FDA Adverse Event Death Summary report: N

SURGICAL ABSORBABLE HEMOSTAT

MDR report key: 1490832 · Received September 25, 2009

Report

Report Number
2210968-2009-01085
Event Type
Death
Date Received
September 25, 2009
Date of Event
June 17, 2009
Report Date
August 27, 2009
Manufacturer
ETHICON, INC.
Product Code
LMF
PMA / PMN Number
N12159
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
NOT APPLICABLE

Narratives

Additional Manufacturer Narrative · 1

DATE SENT TO THE FDA: 09/24/2009. CONCLUSION - NO CONCLUSION CAN BE DRAWN AT THIS TIME. SHOULD ADDITIONAL INFO BE OBTAINED, A SUPPLEMENTAL 3500A FORM WILL BE SUBMITTED ACCORDINGLY.

Description of Event or Problem · 1

IT WAS REPORTED THAT A PT UNDERWENT A CORONARY ARTERY BYPASS GRAFTING X4, AORTIC VALVE REPLACEMENT, AND LEFT CAROTID ENDARTERECTOMY IN 2009. AT THE COMPLETION OF THE SURGERY, THE HEART WAS DE-AIRED AND THE PT WAS WEANED FROM CARDIOPULMONARY BYPASS. THERE WAS BLEEDING FROM THE REGION OF THE OM GRAFT WHICH WAS OVER SEWED WITH PROLENE WHICH REDUCED THE BLEEDING. THE FIBRILLAR ABSORBABLE HEMOSTAT AND FLOSEAL WERE UTILIZED AS PACKING IN THIS AREA TO CONTROL BLEEDING. THE PT HAD GLOBAL BIVENTRICULAR DYSFUNCTION WHICH WAS UNRESPONSIVE TO EPINEPHRINE. CPR WAS INITIATED AND THE PT WAS SUPPORTED BY BYPASS. THE PT'S EEG WAS FLAT AND IT WAS DETERMINED THAT IT WAS AN IRREVERSIBLE SITUATION AND THE PT WAS DECLARED DEAD. THE AUTOPSY REPORT WHICH WAS PROVIDED TO BAXTER STATES "EMBOLIZATION OF FOREIGN MATERIAL CONSISTENT WITH MANUFACTURED PRO-THROMBOTIC MATERIAL INTO THE CORONARY CIRCULATION, WITH INVOLVEMENT OF NUMEROUS INTRAMYOCARDIAL AND EPICARDIAL VESSELS."

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 SURGICAL ABSORBABLE HEMOSTAT HEMOSTATIC AGENT, ABSORBABLE LMF ETHICON, INC. NA UNK

Patients

Seq Age Sex Outcome Treatment
1 76 YR Death| R FLOSEAL